Literature DB >> 21218720

Causes of blindness in people aged 50 years and over: community-based versus hospital-based study.

S A Al-Akily1, M A Bamashmus, K A Al-Mohammadi.   

Abstract

The causes of blindness in Yemen were determined in people aged 50+ years in both a community- and hospital-based study and documented using WHO/PBL criteria. In the community sample of 707 individuals in a rural area of Taiz governorate the prevalence of bilateral blindness was 7.9% and the main causes were cataract (71.4%) and age-related macular degeneration (ARMD) (14.3%). Corneal opacities and uncorrected aphakia were rare (1 case each) and there were no cases of diabetic retinopathy. Unilateral blindness was found in 8.6% of the community sample. In a case-notes review of 1320 new patients attending an eye clinic in Sana'a, bilateral blindness was documented in 26.5% and unilateral blindness in 9.0% (main causes: cataract, glaucoma, ARMD, diabetic retinopathy, corneal opacities and trauma.

Entities:  

Mesh:

Year:  2010        PMID: 21218720

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  3 in total

1.  Cataract surgical rate in Yemen: 2012.

Authors:  Saleh A Al-Akily; Mutahar Y AlShaer; Mahfouth A Bamashmus; Abdulmoghni O AlBarrag; Tawfik K Alkhatib; Hisham A Al-Akhlee
Journal:  Saudi J Ophthalmol       Date:  2016-12-01

2.  Prevalence of trachoma in Yemen: results of population-based prevalence surveys of 42 evaluation units in nine governorates.

Authors:  Adnan Ali Thabit; Tawfik Al-Khatib; Wagdi Hazaea Mohammed Hail; Ahmed Al-Soofi; Najib Abdulaziz Abdullah Thabit; Jamal Boather; Abdulkgabbar Abdullah; Rebecca Mann Flueckiger; Alexandre L Pavluck; Rebecca Willis; Paul Courtright; Colin K Macleod; Anthony W Solomon
Journal:  Ophthalmic Epidemiol       Date:  2018-12       Impact factor: 1.648

Review 3.  Ophthalmic services during ongoing conflict: the eye health system in Yemen.

Authors:  David McMaster; Mahfouth Abdallah Bamashmus
Journal:  BMJ Glob Health       Date:  2019-10-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.